PL EN
REVIEW PAPER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
In recent years, public awareness of Lyme disease has significantly increased, but little is mentioned about infection in pregnant women and the associated risk for the course of pregnancy and foetal development. Borrelia spirochetes can be transmitted vertically, therefore, there is a possibility of infection in the developing foetus. The aim of the study is to present the current state of knowledge on the occurrence of Lyme disease during pregnancy and its consequences for the mother, foetus, and child.

Review methods:
A systematic review of scientific reports on Lyme disease, and Lyme disease in pregnant women was carried out. For this purpose, bibliographic databases such as PubMed and Google Schoolar were used. The following keywords and combinations were applied: Lyme disease, Lyme disease during pregnancy, and Borrelia burgdorferi.

Brief description of the state of knowledge:
The course of borreliosis in pregnant women does not differ from the clinical course observed in other patients. However, the occurring symptoms constitute a significant threat to the maintenance of pregnancy, and also pose the risk of complications during its course. Despite research conducted to-date, it has not been possible to equivocally exclude or confirm the teratogenic effect of Lyme disease. The potential consequences include, among others, premature birth, stillbirth, and the occurrence of congenital defects concerning primarily the nervous, urinary, and cardiovascular systems.

Summary:
Unfortunately, there is still no clear data on the consequences of Lyme disease during pregnancy, and theconclusions drawn from the research are often contradictory. This indicates the need for further studies concerning this issue. However, before achieving this, the emphasis should be placed on raising public awareness, especially among women planning pregnancy.

 
REFERENCES (43)
1.
Gupta RS. Distinction between Borrelia and Borreliella is more robustly supported by molecular and phenotypic characteristics than all other neighbouring prokaryotic genera: Response to Margos’ et al. “The genus Borrelia reloaded” (PLoS ONE 13(12): E0208432). PLoS One. 2019; 14(8): 1–22. doi:10.1371/journal.pone.0221397.
 
2.
Smoleńska Ż, Matyjasek A, Zdrojewski Z. Borelioza – najnowsze reko- mendacje w diagnostyce i leczeniu. Forum Reumatol. 2016; 2(2): 58–64.
 
3.
Carriveau A, Poole H, Thomas A. Lyme Disease. Nurs Clin North Am. 2019; 54(2): 261–275. doi:10.1016/j.cnur.2019.02.003.
 
4.
Cardenas-de la Garza JA, De la Cruz-Valadez E, Ocampo-Candiani J, et al. Clinical spectrum of Lyme disease. Eur J Clin Microbiol Infect Dis. 2019; 38(2): 201–208. doi:10.1007/s10096-018-3417-1.
 
5.
Waddell LA, Greig J, Robbin L, et al. A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn. PLoS One. 2018; 13(11): 1–27. doi:10.1371/journal.pone.0207067.
 
6.
Lambert JS. An Overview of Tickborne Infections in Pregnancy and Outcomes in the Newborn: The Need for Prospective Studies. Front Med. 2020; 7. doi:10.3389/fmed.2020.00072.
 
7.
Barbour AG, Benach JL. Discovery of the lyme disease agent. MBio. 2019; 10(5): 1–13. doi:10.1128/mBio.02166-19.
 
8.
Poinar G. Fossilized mammalian erythrocytes associated with a tick reveal ancient piroplasms. J Med Entomol. 2017; 54(4): 895–900. doi:10.1093/jme/tjw247.
 
9.
Poinar G. Spirochete-like cells in a Dominican amber Ambylomma tick (Arachnida: Ixodidae). Hist Biol. 2015; 27(5): 565–570. doi:10.108 0/08912963.2014.897699.
 
10.
Penza P, Moniuszko-Malinowska A, Czupryna P, et al. Borrelia burgdor- feri – morphological structure and motility as adaptation for trans-mission and survival in the habitat of a tick-vertebrate setup. Przegl Epidemiol. 2016; 70(3): 420–427.
 
11.
Grąźlewska W, Holec-Gąsior L. Recombinant Antigens in Serological Diagnosis of Lyme Borreliosis. Postępy Mikrobiol – Adv Microbiol. 2019; 58(4): 399–413. doi:10.21307/pm-2019.58.4.399.
 
12.
Fiecek B, Chmielewski T. Gorączki powrotne. Postep Mikrobiol – Adv Microbiol. 2018; 57(1): 41–46.
 
13.
Robles A, Fong J, Cervantes J. Borrelia infection in Latin America. Rev Investig Clin. 2018; 70(4): 158–163. doi:10.24875/RIC.18002509.
 
14.
Lewandowski D, Urbanowicz A, Figlerowicz M. Molekularne Podłoże Oddziaływań Pomiędzy Borrelia Burgdorferi, kleszczem i kręgowcem. Postępy Mikrobiol. 2013; 52(1): 9–16.
 
15.
Černý J, Lynn G, Hrnková J, et al. Management options for Ixodes ricinus-associated pathogens: A review of prevention strategies. Int J Environ Res Public Health. 2020; 17(6): 1–18. doi:10.3390/ijerph17061830.
 
16.
Cook MJ, Puri BK. Estimates for Lyme borreliosis infections based on models using sentinel canine and human seroprevalence data. Infect Dis Model. 2020; 5: 871–888. doi:10.1016/j.idm.2020.10.004.
 
17.
Vandekerckhove O, De Buck E, Van Wijngaerden E. Lyme disease in Western Europe: an emerging problem? A systematic review. Acta Clin Belgica Int J Clin Lab Med. 2021; 76(3): 244–252. https://doi.org/10.10 80/17841886.2019.1694293.
 
18.
Bush LM, Vazquez-Pertejo MT. Tick borne illness–Lyme disease. Disease- -a-Month. 2018; 64(5): 195–212. doi:10.1016/j.disamonth.2018.01.007.
 
19.
Zakład Epidemiologii NIZP-PZH. Zachorowania na wybrane choro- by zakaźne w Polsce od 1 stycznia do 31 grudnia 2020 r. oraz w porównywalnym okresie 2019 r. http://wwwold.pzh.gov.pl/oldpa... meld/2020/index_mp.html (access: 2021. 03. 15).
 
20.
Salamon D, Gosiewski T, Bulanda M. Borelioza z Lyme – niebezpieczna pułapka. Zakażenia (Krak). 2015; 15(2): 69–75.
 
21.
Halperin JJ. Neuroborreliosis. Neurol Clin. 2018; 36(4): 821–830. doi:10.1016/j.ncl.2018.06.006.
 
22.
Steere AC, Strle F, Wormser GP, et al. Lyme borreliosis. Nat Rev Dis Prim. 2016; 2. doi:10.1038/nrdp.2016.90.
 
23.
NICE guideline. Lyme disease. https://www.nice.org.uk/guidan... (access: 2021. 11. 25).
 
24.
Jansweijer JA, van Oort RJ. Tricky ticks: The importance of lyme carditis recognition. Netherlands Hear J. 2015; 23(11): 531–532. doi:10.1007/ s12471-015-0745-y.
 
25.
Pancewicz SA. Borelioza z Lyme – Zasady rozpoznawania i leczenia. Pediatr i Med Rodz. 2015; 10(2): 163–173. doi:10.15557/PiMR.2014.0020.
 
26.
Woś H. Borreliosis, tick-transmitted diseases. Pediatr Pol. 2010; 85(4): 371–374. doi:10.1016/s0031-3939(10)70011-1.
 
27.
Śliwa L. Teratogenny wpływ bakterii Borrelia sp. na płody matek cho- rujących na boreliozę z Lyme. Nowa Med. 2011; 4: 62–65.
 
28.
Maraspin V, Lusa L, Blejec T, et al. Course and Outcome of Erythema Migrans in Pregnant Women. J Clin Med. 2020; 9(8): 2364. doi:10.3390/jcm9082364.
 
29.
Strobino BA, Williams CL, Abid S, et al. Lyme disease and pregnan- cy outcome: A prospective study of two thousand prenatal patients. Am J Obstet Gynecol. 1993; 169(2 Pt 1): 367–374. doi:10.1016/0002- 9378(93)90088-Z.
 
30.
Hercogova J, D.Vanousova. Syphilis and borreliosis during pregnancy. Dermatol Ther. 2008; 21: 205–209.
 
31.
Figueroa R, Bracero LA, Aguero-Rosenfeld M, et al. Confirmation of borrelia burgdorferi spirochetes by polymerase chain reaction in placentas of women with reactive serology for lyme antibodies. Gynecol Obstet Invest. 1996; 41(4): 240–243. doi:10.1159/000292277.
 
32.
Lakos A, Solymosi N. Maternal Lyme borreliosis and pregnancy outcome. Int J Infect Dis. 2010; 14(6): 494–498. doi:10.1016/j.ijid.2009.07.019.
 
33.
Alexander JM, Cox SM, Alexander JM. Lyme Disease and Pregnancy. Infect Dis Obstet Gynecol. 1995; 3(6): 256–261. doi:10.1155/S1064744995000755.
 
34.
Pancewicz S, Moniuszko-Malinowska A, Garlicki A, et al. Diagnostyka i leczenie boreliozy z Lyme. Standardy Polskiego Towarzystwa Epidemiologów i Lekarzy Chorób Zakaźnych. http://www.pteilchz.org.pl/ informacje/rekomendacje/ (access: 2021. 02. 12).
 
35.
Chmielewski T, Dunaj J, Gołąb E, et al. Rekomendacje Krajowej Izby Diagnostów Laboratoryjnych “Diagnostyka laboratoryjna chorób odkleszczowych.” https://kidl.org.pl/get-file/1.... pdf (access: 2021.11.25).
 
36.
Garcia-Monco JC, Benach JL. Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections. Ann Neurol. 2019; 85(1): 21–31. doi:10.1002/ana.25389.
 
37.
Grąźlewska W, Ferra B, Holec-Gąsior L. Przydatność Diagnostyczna Reakcji Pcr w Rozpoznawaniu Boreliozy. Postępy Mikrobiol – Adv Microbiol. 2020; 59(4): 367–377. doi:10.21307/pm-2020.59.4.28.
 
38.
O’Brien JM, Hamidi O. Borreliosis Infection during Pregnancy. Ann Clin Cytol Pathol. 2017; 3(8): 1085.
 
39.
Eldin C, Raffetin A, Bouiller K, et al. Review of European and American guidelines for the diagnosis of Lyme borreliosis. Med Mal Infect. 2019;49(2): 121–132. doi:10.1016/j.medmal.2018.11.011.
 
40.
Müllegger RR, Häring NS, Glatz M. Skin infections in pregnancy. Clin Dermatol. 2016; 34(3): 368–377. doi:10.1016/j.clindermatol.2016.02.009.
 
41.
Smith GN, Moore KM, Hatchette TF, et al. Committee Opinion No. 399: Management of Tick Bites and Lyme Disease During Pregnancy: (En français: Prise en charge des morsures de tiques et de la maladie de Lyme pendant la grossesse). J Obstet Gynaecol Canada. 2020; 42(5): 644–653. doi:10.1016/j.jogc.2020.01.001.
 
42.
Sroka J, Wójcik-Fatla A, Dutkiewicz J, et al. Profilaktyka chorób od- kleszczowych. Bezpieczeństwo Pr Nauk i Prakt. 2014; 4: 21–23.
 
43.
Woźniak M, Brukwicka I, Kopański Z, et al. Związki stylu życia ze zdrowiem [The relationship between lifestyle and health]. J Clin Healthc. 2015; (4): 4–9.
 
eISSN:2084-4905
ISSN:2083-4543